Febuxostat Tablet, Film Coated
Product Images NDC 67877-668

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 67877-668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Feb-40mg-100s-carton (Feb 40mg 100s Carton)

Feb-40mg-100s-carton (Feb 40mg 100s Carton)
This is a description of Febuxostat tablets, which come in a bottle containing 100 tablets (10 unit doses of 10 tablets). It is treated as a prescription-only drug, and patients are recommended to receive an enclosed medication guide with every bottle. The usual dosage instructions for Febuxostat can be found in the package insert. Each tablet contains 40mg of febuxostat. The storage instructions recommend that the tablets be protected from light and stored at a temperature range of 20°C to 25°C (68°F to 77°F) with brief excursions permitted between 15°C to 30°C (59°F to 86°F). The manufacturer is Alkem Laboratories Ltd, based in India; the distributor is unknown.*
FDA Label Image

Feb-40mg-30s-bottle (Feb 40mg 30s Bottle)

Feb-40mg-30s-bottle (Feb 40mg 30s Bottle)
Febuxostat tablets are available in a dosage of 40 mg and should not be accepted if the seal over the bottle opening is broken or missing. The package insert contains information about indications and dosage. The tablets should be protected from light, stored at a temperature of 20°C to 25°C (88°F to TT°F), with excursions between 15°C to 30°C (59°F to 86°F). The manufacturer is Alkem Laboratories Ltd. and the distributor is Ascend Laboratories, LLC. The medication guide should be dispensed to each patient. The label on the bottle should include the text "TGN" and an unvarnished area of 44x20 mm (LXH) with UV Varnish.*
FDA Label Image

Feb-80mg-100s-carton (Feb 80mg 100s Carton)

Feb-80mg-100s-carton (Feb 80mg 100s Carton)
Febuxostat Tablets are available as a prescription medication in the form of blister packs containing 100 tablets. Each tablet contains 80mg of Febuxostat. The medication guide included with the prescription should be dispensed to each patient. The tablets should be stored at 20°C to 25°C (68°F to 77°F) and protected from light. The usual dosage should be checked in the package insert for indications and dosage information. The manufacturer is Alkem Laboratories Ltd. from Mumbai, India, and the tablets are distributed by Ascend Laboratories in New Jersey, USA.*
FDA Label Image

Feb-80mg-30s-bottle (Feb 80mg 30s Bottle)

Feb-80mg-30s-bottle (Feb 80mg 30s Bottle)
Each tablet of Febuxostat contains 80mg of the active ingredient. This medication should not be accepted if the seal over the bottle opening is broken. The usual dosage and other important information can be found in the package insert. Febuxostat should be protected from light and stored at temperatures ranging from 20°C to 25°C. Dispense the enclosed medication guide to each patient. Febuxostat is manufactured by Akem Laboratories Ltd. and distributed by Ascend Laboratories. This product is only available with a prescription.*
FDA Label Image

Febuxostat-structure (Feb Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.